BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16024900)

  • 1. Is dementia reversible in patients with neurocysticercosis?
    Ramirez-Bermudez J; Higuera J; Sosa AL; Lopez-Meza E; Lopez-Gomez M; Corona T
    J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1164-6. PubMed ID: 16024900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of cognitive impairment in neurocysticercosis: differences according to disease phase.
    Rodrigues CL; de Andrade DC; Livramento JA; Machado LR; Abraham R; Massaroppe L; Lucato LT; Caramelli P
    Neurology; 2012 Mar; 78(12):861-6. PubMed ID: 22402863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocysticercosis: surgical treatment of an autochthonous case in a non-endemic region.
    Bruschi F; Giangaspero F; Castagna M; Becherini F; Filice ME; Vannozzi R; Cantini R
    Pathologica; 2006 Aug; 98(4):229-31. PubMed ID: 17175791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy.
    Singhi P; Ray M; Singhi S; Khandelwal N
    J Child Neurol; 2000 Apr; 15(4):207-13. PubMed ID: 10805184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases.
    Gogia S; Talukdar B; Choudhury V; Arora BS
    Trans R Soc Trop Med Hyg; 2003; 97(4):416-21. PubMed ID: 15259471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study.
    Das K; Mondal GP; Banerjee M; Mukherjee BB; Singh OP
    J Clin Neurosci; 2007 Dec; 14(12):1172-7. PubMed ID: 17964789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ecuadorian immigrant with headache].
    Ortega-Herrera R; Fernández-Segura ME; Gómez de Travecedo Y Calvo I
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):248-9. PubMed ID: 15056443
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic brain edema in neurocysticercosis].
    Agapejev S; Yela DA; Gomes AE
    Arq Neuropsiquiatr; 1998 Sep; 56(3B):569-76. PubMed ID: 9850752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of albendazole treatment on seizure outcomes in patients with symptomatic neurocysticercosis.
    Romo ML; Wyka K; Carpio A; Leslie D; Andrews H; Bagiella E; Hauser WA; Kelvin EA;
    Trans R Soc Trop Med Hyg; 2015 Nov; 109(11):738-46. PubMed ID: 26433183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant steroid and albendazole for treating neurocysticercosis.
    Shahid SK; Singhi PD
    Indian Pediatr; 1999 Nov; 36(11):1176. PubMed ID: 10745352
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticysticercal treatment and seizures in neurocysticercosis.
    Singh G; Sander JW
    Lancet Neurol; 2004 Apr; 3(4):207-8. PubMed ID: 15039032
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial.
    Kalra V; Dua T; Kumar V
    J Pediatr; 2003 Jul; 143(1):111-4. PubMed ID: 12915835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the complex associations over time among albendazole treatment, cyst evolution, and seizure outcomes in neurocysticercosis.
    Carpio A; Chang M; Zhang H; Romo ML; Jaramillo A; Hauser WA; Kelvin EA
    Epilepsia; 2019 Sep; 60(9):1820-1828. PubMed ID: 31355931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment and dementia in neurocysticercosis: a cross-sectional controlled study.
    Ciampi de Andrade D; Rodrigues CL; Abraham R; Castro LH; Livramento JA; Machado LR; Leite CC; Caramelli P
    Neurology; 2010 Apr; 74(16):1288-95. PubMed ID: 20404310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Long-Term Outcomes Between 7 Days and 28 Days Albendazole Monotherapy in the Treatment of Single-Lesion Neurocysticercosis in Children.
    Johnson N; Saini AG; Malhi P; Khandelwal N; Singhi P
    J Child Neurol; 2022 Jan; 37(1):28-34. PubMed ID: 34641721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset seizures.
    Clark BM; Agan BK
    Am Fam Physician; 2007 Jun; 75(11):1705-6. PubMed ID: 17575664
    [No Abstract]   [Full Text] [Related]  

  • 18. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
    Thussu A; Chattopadhyay A; Sawhney IM; Khandelwal N
    J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):272-5. PubMed ID: 17928325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraventricular neurocysticercosis: 18 consecutive patients and review of the literature.
    Cuetter AC; Andrews RJ
    Neurosurg Focus; 2002 Jun; 12(6):e5. PubMed ID: 15926784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocysticercosis-induced hemiballismus in a child.
    Karnik PS; Tullu MS; David JJ; Ghildiyal RG
    J Child Neurol; 2011 Jul; 26(7):904-6. PubMed ID: 21427444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.